Inflectra
Bucking Trend, Kaiser Boosts Biosimilar Uptake
Adoption of infliximab biosimilars has been negligible across the United States, but Kaiser Permanente Northwest ...
FEBRUARY 14, 2019
FDA Approves Inflectra, Biosimilar to Remicade
Inflectra is the second U.S. biosimilar approved and the first monoclonal antibody.
APRIL 6, 2016
Load more